Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke …

JD Easton, JL Saver, GW Albers, MJ Alberts… - Stroke, 2009 - Am Heart Assoc
This scientific statement is intended for use by physicians and allied health personnel caring
for patients with transient ischemic attacks. Formal evidence review included a structured …

Cryptogenic stroke

JL Saver - New England Journal of Medicine, 2016 - Mass Medical Soc
Key Clinical Points Cryptogenic Stroke One quarter of patients with ischemic stroke have no
probable cause found after standard workup, including echocardiography, inpatient cardiac …

Thrombectomy for distal, medium vessel occlusions: a consensus statement on present knowledge and promising directions

JL Saver, R Chapot, R Agid, AE Hassan, AP Jadhav… - Stroke, 2020 - Am Heart Assoc
Endovascular thrombectomy (EVT) is well established as a highly effective treatment for
acute ischemic stroke (AIS) due to proximal, large vessel occlusions (PLVOs). With iterative …

[HTML][HTML] Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke

JL Saver, M Goyal, A Bonafe, HC Diener… - … England Journal of …, 2015 - Mass Medical Soc
Background Among patients with acute ischemic stroke due to occlusions in the proximal
anterior intracranial circulation, less than 40% regain functional independence when treated …

Time is brain—quantified

JL Saver - Stroke, 2006 - Am Heart Assoc
Background and Purpose— The phrase “time is brain” emphasizes that human nervous
tissue is rapidly lost as stroke progresses and emergent evaluation and therapy are required. …

[HTML][HTML] Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct

…, WS Smith, DS Liebeskind, JL Saver… - … England Journal of …, 2018 - Mass Medical Soc
Background The effect of endovascular thrombectomy that is performed more than 6 hours
after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is …

Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke

JL Saver, GC Fonarow, EE Smith, MJ Reeves… - Jama, 2013 - jamanetwork.com
… Dr Saver reports serving as a member of the Get With the Guidelines (GWTG) Science
Subcommittee; as a scientific consultant regarding trial design and conduct to Covidien, CoAxia, …

Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis

JL Saver, M Goyal, AAD Van der Lugt, BK Menon… - Jama, 2016 - jamanetwork.com
… Dr Saver reports being an employee of the University of California; serving as an unpaid …
neither the University of California nor Dr Saver received any payments for this voluntary service…

[HTML][HTML] Long-term outcomes of patent foramen ovale closure or medical therapy after stroke

JL Saver, JD Carroll, DE Thaler… - … England Journal of …, 2017 - Mass Medical Soc
Background Whether closure of a patent foramen ovale reduces the risk of recurrence of
ischemic stroke in patients who have had a cryptogenic ischemic stroke is unknown. Methods In …

Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial

JL Saver, R Jahan, EI Levy, TG Jovin, B Baxter… - The Lancet, 2012 - thelancet.com
Background The Solitaire Flow Restoration Device is a novel, self-expanding stent retriever
designed to yield rapid flow restoration in acute cerebral ischaemia. We compared the …